<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Georgia State University &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/georgia-state-university/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 25 Oct 2026 13:02:55 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Georgia State University &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Collagen-Targeted MRI Agent Spots Tiny Lung Tumors and Hidden Metastases in Preclinical Tests</title>
		<link>https://bioengineer.org/collagen-targeted-mri-agent-spots-tiny-lung-tumors-and-hidden-metastases-in-preclinical-tests/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sun, 25 Oct 2026 13:02:55 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[collagen type I]]></category>
		<category><![CDATA[Early Detection]]></category>
		<category><![CDATA[Georgia State University]]></category>
		<category><![CDATA[lung adenocarcinoma]]></category>
		<category><![CDATA[lung cancer]]></category>
		<category><![CDATA[Metastasis]]></category>
		<category><![CDATA[molecular imaging]]></category>
		<category><![CDATA[MRI contrast agent]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<category><![CDATA[preclinical study]]></category>
		<category><![CDATA[Science Advances]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=453640</guid>

					<description><![CDATA[A collagen-targeted protein MRI contrast agent developed at Georgia State University detected invasive lung tumors and multi-organ metastases as small as 1 millimeter in preclinical studies, and researchers are now pursuing FDA clinical testing.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">453640</post-id>	</item>
	</channel>
</rss>
